Patent · US Active

Use of minaprine to reduce tumor growth

US11517575B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 23, 2019
Grant dateDec 6, 2022
Priority date
Expiry dateJan 23, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is drawn to the use of Minaprine dihydrochloride and analogs thereof, for reducing tumor growth when administered to a patient suffering from cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.